本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mirum Pharmaceuticals, Inc.

98.22
-2.3900-2.38%
盤後98.220.00000.00%19:30 EDT
成交量:44.11萬
成交額:4,362.84萬
市值:63.78億
市盈率:-6.98
高:103.28
開:102.78
低:97.80
收:100.61
52周最高:130.00
52周最低:63.23
股本:6,493.22萬
流通股本:5,641.51萬
量比:0.86
換手率:0.78%
股息:- -
股息率:- -
每股收益(TTM):-14.0800
每股收益(LYR):-0.4700
淨資產收益率:-702.97%
總資產收益率:-6.79%
市淨率:-611.94
市盈率(LYR):-208.98

資料載入中...

2020/03/12

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/03/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/17

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2020/01/14

重要事件披露

Current report, items 5.02, 8.01, and 9.01
2020/01/06

SEC問詢函

[Cover]Correspondence
2020/01/06

SEC問詢函

[Cover]Correspondence
2020/01/06

招股説明書

General form for registration of securities under the Securities Act of 1933
2019/12/27

重要事件披露

Current report, items 5.02 and 9.01
2019/12/16

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/09/10

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/28

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/28

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/08/28

重要事件披露

Current report, items 2.02 and 9.01
2019/08/01

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/30

超過5%披露

General statement of acquisition of beneficial ownership
2019/07/26

超過5%披露

General statement of acquisition of beneficial ownership